LGALS3 expression profile based on
OV : Ovarian serous cystadenocarcinoma Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Stage1-vs-Stage2
N/A
Stage1-vs-Stage3
N/A
Stage1-vs-Stage4
N/A
Stage2-vs-Stage3
8.360400E-01
Stage2-vs-Stage4
6.807900E-02
Stage3-vs-Stage4
8.318100E-03
Pan-cancer view
Survival
Correlated genes
DepMap
OV : Ovarian serous cystadenocarcinoma Note
Patient race information is not available for 12 samples, while 2 samples from Amerian Indian and one sample from Native Hawaiians not considered in above plot.
Show statistics
Hide statistics
Comparison Statistical significance
Caucasian-vs-AfricanAmerican
3.983400E-01
Caucasian-vs-Asian
1.729550E-01
AfricanAmerican-vs-Asian
1.161150E-01
Pan-cancer view
Survival
Correlated genes
DepMap
OV : Ovarian serous cystadenocarcinoma Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.998220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.678300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.757300E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.237900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.863900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.998400E-02
Pan-cancer view
Survival
Correlated genes
DepMap
OV : Ovarian serous cystadenocarcinoma Note
Tumor grade information is not available for 3 samples, undetermined for 4 samples and borderline cancerous for 2 samples.
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Grade 1-vs-Grade 2
N/A
Grade 1-vs-Grade 3
N/A
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
6.470600E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Survival
Correlated genes
DepMap
OV : Ovarian serous cystadenocarcinoma Note
Whole exome sequencing data is not available for 87 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data.
Show statistics
Hide statistics
Comparison Statistical significance
TP53-Mutant-vs-TP53-NonMutant
6.904100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
